The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Machine learning in preclinical drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Evolutionary-scale prediction of atomic level protein structure with a language model
Lin, Z., Akin, H., Rao, R., Hie, B., Zhu, Z., Lu, W., Smetanin, N., Verkuil, R., Kabeli, O., Shmueli, Y., et al. (2022) · doi:10.1101/2022.07.20.500902 · Cited by 5,990
Accurate prediction of protein structures and interactions using a 3-track network
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021) · doi:10.1101/2021.06.14.448402 · Cited by 5,549
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Research works printed but not linked: 71
- Schenone, M., Dančík, V., Wagner, B. K. & Clemons, P. A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9, 232–240 (2013). · DOI · Paper page
- Ashenden, S. K. in The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry Ch. 6 (Elsevier, 2021). · DOI
- Janai, J., Güney, F., Behl, A. & Geiger, A. Computer vision for autonomous vehicles: problems, datasets and state of the art. Found. Trends Comp. Graph. Vis. 12, 1–308 (2020).
- Peterson, A. A. & Liu, D. R. Small-molecule discovery through DNA-encoded libraries. Nat. Rev. Drug Discov. 22, 699–722 (2023). · DOI · Paper page
- Lim, K. S. et al. Machine learning on DNA-encoded library count data using an uncertainty-aware probabilistic loss function. J. Chem. Inf. Model. 62, 2316–2331 (2022). · DOI
- Hou, R., Xie, C., Gui, Y., Li, G. & Li, X. Machine-learning-based data analysis method for cell-based selection of DNA-encoded libraries. ACS Omega 8, 19057–19071 (2023). · DOI
- Van de Sande, B. et al. Applications of single-cell RNA sequencing in drug discovery and development. Nat. Rev. Drug Discov. 22, 496–520 (2023). · DOI · Paper page
- Chen, J. et al. Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data. Nat. Commun. 13, 6494 (2022). · DOI · Paper page
- Godinez, W. J., Hossain, I., Lazic, S. E., Davies, J. W. & Zhang, X. A multi-scale convolutional neural network for phenotyping high-content cellular images. Bioinformatics 33, 2010–2019 (2017). · DOI · Paper page
- Jin, W. et al. Deep learning identifies synergistic drug combinations for treating COVID-19. Proc. Natl Acad. Sci. USA 118, e2105070118 (2021). · DOI · Paper page
- Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742–754 (2010). · DOI · Paper page
- Fernández-De Gortari, E., García-Jacas, C. R., Martinez-Mayorga, K. & Medina-Franco, J. L. Database fingerprint (DFP): an approach to represent molecular databases. J. Cheminform. 9, 9 (2017).
- Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. https://doi.org/10.1038/s41589-023-01349-8 (2023). · DOI · Paper page
- Corsello, S. M. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat. Med. 23, 405–408 (2017). · DOI · Paper page
- Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177–185 (2024). · DOI · Paper page
- Tropsha, A., Isayev, O., Varnek, A., Schneider, G. & Cherkasov, A. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR. Nat. Rev. Drug Discov. 23, 141–155 (2024). · DOI · Paper page
- Rossetti, G. G. et al. Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits. Sci. Rep. 12, 2505 (2022). · DOI
- Anstine, D. M. & Isayev, O. Generative models as an emerging paradigm in the chemical sciences. J. Am. Chem. Soc. 145, 8736–8750 (2023). · DOI · Paper page
- Jin, W., Barzilay, R. & Jaakkola, T. Junction tree variational autoencoder for molecular graph generation. Preprint at arxiv.org/abs/1802.04364 (2018). · arXiv
- Godinez, W. J. et al. Design of potent antimalarials with generative chemistry. Nat. Mach. Intell. 4, 180–186 (2022). · DOI
- Cesaro, A., Bagheri, M., Torres, M., Wan, F. & de la Fuente-Nunez, C. Deep learning tools to accelerate antibiotic discovery. Expert Opin. Drug Discov. 18, 1245–1257 (2023). · DOI
- Rezende, D. J. & Mohamed, S. Variational inference with normalizing flows. In Proc. 32nd International Conference on Machine Learning 2, 1530–1538 (PMLR, 2015).
- Shekhovtsov, A., Schlesinger, D. & Flach, B. VAE approximation error: ELBO and exponential families. Preprint at arxiv.org/abs/2102.09310 (2021). · arXiv
- Shi, C. et al. GraphAF: a flow-based autoregressive model for molecular graph generation. Preprint at arxiv.org/abs/2001.09382 (2020). · arXiv
- Hoogeboom, E., Satorras, V. G., Vignac, C. & Welling, M. Equivariant diffusion for molecule generation in 3D. In Proc. 39th International Conference on Machine Learning 8867–8887 (2022).
- Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model. 28, 31–36 (1988).
- Grisoni, F. Chemical language models for de novo drug design: challenges and opportunities. Curr. Opin. Struct. Biol. 79, 102527 (2023). · DOI
- Flam-Shepherd, D., Zhu, K. & Aspuru-Guzik, A. Language models can learn complex molecular distributions. Nat. Commun. 13, 3293 (2022). · DOI · Paper page
- Skinnider, M. A., Greg Stacey, R., Wishart, D. S. & Foster, L. J. Chemical language models enable navigation in sparsely populated chemical space. Nat. Mach. Intell. 3, 759–770 (2021). · DOI · Paper page
- Moret, M., Friedrich, L., Grisoni, F., Merk, D. & Schneider, G. Generative molecular design in low data regimes. Commun. Chem. 5, 129 (2022). · DOI
- Ballarotto, M. et al. De novo design of Nurr1 agonists via fragment-augmented generative deep learning in low-data regime. J. Med. Chem. 66, 8170–8177 (2023). · DOI
- Moret, M. et al. Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nat. Commun. 14, 114 (2023). · DOI · Paper page
- Grisoni, F. et al. Combining generative artificial intelligence and on-chip synthesis for de novo drug design. Sci. Adv. 7, 3338–3349 (2021). · DOI · Paper page
- Vaswani, A. et al. Attention is all you need. Preprint at arxiv.org/abs/1706.03762 (2023). · arXiv
- Bagal, V., Aggarwal, R., Vinod, P. K. & Priyakumar, U. D. MolGPT: molecular generation using a transformer-decoder model. J. Chem. Inf. Model. 62, 2064–2076 (2021). · DOI · Paper page
- Born, J. & Manica, M. Regression Transformer enables concurrent sequence regression and generation for molecular language modelling. Nat. Mach. Intell. 5, 432–444 (2023). · DOI
- Grechishnikova, D. Transformer neural network for protein-specific de novo drug generation as a machine translation problem. Sci. Rep. 11, 321 (2021). · DOI · Paper page
- Stsiapanava, A. et al. Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH. Nat. Struct. Mol. Biol. 29, 190–193 (2022). · DOI
- Liu, H. et al. Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles. Sci. Adv. 8, eabo4184 (2022). · DOI
- Yang, Q. et al. Structural comparison and drug screening of spike proteins of ten SARS-CoV-2 variants. Research 2022, 9781758 (2022).
- Yang, Q., Xia, D., Syed, A. A. S., Wang, Z. & Shi, Y. Highly accurate protein structure prediction and drug screen of monkeypox virus proteome. J. Infect. 86, 66–117 (2023). · DOI
- Berman, H. M. The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000). · DOI · Paper page
- Michaud, J. M., Madani, A. & Fraser, J. S. A language model beats AlphaFold2 on orphans. Nat. Biotechnol. 40, 1576–1577 (2022). · DOI
- Fang, X. et al. A method for multiple-sequence-alignment-free protein structure prediction using a protein language model. Nat. Mach. Intell. 5, 1087–1096 (2023). · DOI · Paper page
- Corso, G., Stärk, H., Barzilay, R. & Jaakkola, T. DiffDock: diffusion steps, twists, and turns for molecular docking. Preprint at arxiv.org/abs/2210.01776 (2022). · arXiv
- Goodnow, R. A. Hit and lead identification: integrated technology-based approaches. Drug Discov. Today Technol. 3, 367–375 (2006). · DOI
- Yang, L. et al. Transformer-based deep learning method for optimizing ADMET properties of lead compounds. Phys. Chem. Chem. Phys. 25, 2377–2385 (2023).
- Chen, Y., Yu, X., Li, W., Tang, Y. & Liu, G. In silico prediction of hERG blockers using machine learning and deep learning approaches. J. Appl. Toxicol. 43, 1462–1475 (2023). · DOI
- Sharma, B. et al. Accurate clinical toxicity prediction using multi-task deep neural nets and contrastive molecular explanations. Sci. Rep. 13, 4908 (2023). · DOI
- Lipinski, C. A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol. 1, 337–341 (2004). · DOI · Paper page
- Coutinho, A. L. et al. A robust, viable, and resource sparing HPLC-based log P method applied to common drugs. Int. J. Pharm. 644, 123325 (2023). · doi:10.1016/j.ijpharm.2023.123325
- Faller, B. & Ertl, P. Computational approaches to determine drug solubility. Adv. Drug Deliv. Rev. 59, 533–545 (2007). · DOI · Paper page
- Aliagas, I., Gobbi, A., Lee, M. L. & Sellers, B. D. Comparison of log P and log D correction models trained with public and proprietary data sets. J. Comput. Aided Mol. Des. 36, 253–262 (2022). · doi:10.1007/s10822-022-00450-9
- Win, Z. M., Cheong, A. M. Y. & Hopkins, W. S. Using machine learning to predict partition coefficient (log P) and distribution coefficient (log D) with molecular descriptors and liquid chromatography retention time. J. Chem. Inf. Model. 63, 1906–1913 (2023). · DOI
- Domingo-Almenara, X. et al. The METLIN small molecule dataset for machine learning-based retention time prediction. Nat. Commun. 10, 5811 (2019). · DOI · Paper page
- Datta, R., Das, D. & Das, S. Efficient lipophilicity prediction of molecules employing deep-learning models. Chemometr. Intell. Lab. Syst. 213, 104309 (2021). · DOI
- Prasad, S. & Brooks, B. R. A deep learning approach for the blind log P prediction in SAMPL6 challenge. J. Comput. Aided Mol. Des. 34, 535–542 (2020). · DOI
- Heijman, J., Voigt, N., Carlsson, L. G. & Dobrev, D. Cardiac safety assays. Curr. Opin. Pharmacol. 15, 16–21 (2014). · DOI
- Huang, R. et al. Tox21Challenge to build predictive models of nuclear receptor and stress response pathways as mediated by exposure to environmental chemicals and drugs. Front. Environ. Sci. https://doi.org/10.3389/fenvs.2015.00085 (2016). · DOI · Paper page
- Ramakrishnan, R., Dral, P. O., Rupp, M. & von Lilienfeld, O. A. Quantum chemistry structures and properties of 134 kilo molecules. Sci. Data 1, 140022 (2014).
- Frye, L., Bhat, S., Akinsanya, K. & Abel, R. From computer-aided drug discovery to computer-driven drug discovery. Drug Discov. Today Technol. 39, 111–117 (2021). · DOI
- Zeng, W., Guo, L., Xu, S., Chen, J. & Zhou, J. High-throughput screening technology in industrial biotechnology. Trends Biotechnol. 38, 888–906 (2020). · DOI · Paper page
- Sarkar, N. & Stokes, J. M. Practical applications of machine learning for anti-infective drug discovery. Med. Chem. Rev. 14, 345–375 (2023). · DOI
- Arnold, A., Alexander, J., Liu, G. & Stokes, J. M. Applications of machine learning in microbial natural product drug discovery. Expert Opin. Drug Discov. 18, 1259–1272 (2023). · DOI
- Mullowney, M. W. et al. Artificial intelligence for natural product drug discovery. Nat. Rev. Drug Discov. 22, 895–916 (2023). · DOI · Paper page
- Grisoni, F. et al. Designing anticancer peptides by constructive machine learning. ChemMedChem 13, 1300–1302 (2018). · DOI · Paper page
- Chen, J., Cheong, H. H. & Siu, S. W. I. xDeep-AcPEP: deep learning method for anticancer peptide activity prediction based on convolutional neural network and multitask learning. J. Chem. Inf. Model. 61, 3789–3803 (2021). · DOI
- Walker, A. S. & Clardy, J. A machine learning bioinformatics method to predict biological activity from biosynthetic gene clusters. J. Chem. Inf. Model. 61, 2560–2571 (2021). · DOI
- Wellawatte, G. P., Gandhi, H. A., Seshadri, A. & White, A. D. A perspective on explanations of molecular prediction models. J. Chem. Theory Comput. 19, 2149–2160 (2023). · DOI
- Cichońska, A. et al. Crowdsourced mapping of unexplored target space of kinase inhibitors. Nat. Commun. 12, 3307 (2021). · DOI
- Ketkar, N. in Deep Learning with Python 97–111 (Apress, 2017). · DOI · Paper page
Cited by
Artificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 498
Hansson, F. G., Madsen, N. G., Hansen, L. G., Jakočiūnas, T., Lengger, B., Keasling, J. D., Jensen, M. K., Acevedo-Rocha, C. G., & Jensen, E. D. (2025) · Nature Communications · doi:10.1038/s41467-025-59418-6 · Cited by 7
Metadata
- Authors
- Catacutan, D. B., Alexander, J., Arnold, A., & Stokes, J. M.
- Venue
- Nature Chemical Biology
- Published
- 2024-07-19
- Volume
- 20
- Issue
- 8
- Pages
- 960-973
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W4400831251
- Cited by
- 204
- References
- 45
- FWCI
- 39.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Funders
- Gouvernement du Canada | Canadian Institutes of Health Research
- The Weston Family Foundation, The David Braley Centre for Antibiotic Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Machine learning in preclinical drug discovery. https://app.cochat.ai/papers/10.1038/s41589-024-01679-1
- The paper
- Catacutan, D. B., Alexander, J., Arnold, A., & Stokes, J. M. (2024). Machine learning in preclinical drug discovery. Nature Chemical Biology. https://doi.org/10.1038/s41589-024-01679-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.